Clinical trial
Risk of Major Adverse Cardiovascular Events Among Users of Naldemedine Compared With Other Medications Used for Opioid Induced Constipation in Adult Patients With Chronic Non-Cancer Pain in a Healthcare Claims Database
NCT03720613 is registered in ClinicalTrials.gov with BioDelivery Sciences International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk of Major Adverse Cardiovascular Events Among Users of Naldemedine Compared With Other Medications Used for Opioid Induced Constipation in Adult Patients With Chronic Non-Cancer Pain in a Healthcare Claims Database
- Lead sponsor
- BioDelivery Sciences International
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 4, 2019
- Completion date
- June 30, 2029
- Enrollment
- 34,532 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.